Adverse drug events are now the fourth leading cause of death in hospitals.
It’s a reasonable bet they are an even greater cause of death in non-hospital settings where there is no one to monitor things going wrong and no one to intervene to save a life. In mental health, for instance, drug-induced problems are the leading cause of death — and these deaths happen in community rather than hospital settings.
There is also another drug crisis — we are failing to discover new drugs. [Read more...]
In response to the recent BMJ editorial on serotonin and depression, there were seventeen letters of which three were published, along with my response. These are copied below along with the best letter – by Barney Carroll – which wasn’t published. Make your own mind up as to why. Another piece of minor intrigue is […]
Editorial Note: This is another post on the vaccination and censorship theme. Elizabeth Hart’s comments, over the past few weeks in response to some of the posts here, on efforts to stifle debate have been balanced and eloquent. Given the growing number of new journalism outlets, such as The Conversation, that portray themselves as tackling […]
Editorial Note: This post is by John Stone at my invitation. I am broadly speaking pro-Vaccination and reluctant to stray into the Vaccination Wars but the issues about free debate in recent posts seem most acute in this domain. Anyone who even thinks about questioning is vilified. There are important public policy issues involved in […]
The BMJ article on The Marketing of Serotonin has stirred some interest. There are some highly technical comments on the BMJ site but of course the key point behind the piece is the rather obvious fact that twenty-five years ago many people were saying it was all a myth. The extraordinary Michael Leunig nailed it […]
Science Media Centre Roundup Expert reaction to editorial on serotonin and depression as published in The BMJ (British Medical Journal)* Dr Clare Stanford, Reader in Experimental Psychopharmacology, UCL, said: “Prof David Healy’s article treads a path that is well-worn but out of date. He argues that selective serotonin re-uptake inhibitors (SSRI) antidepressants are used because […]